24 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 36.9% to $3.86 in pre-market trading after gaining more than 3% on Monday.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Unusual Options Activity Insight: PLx Pharma
Unusual Options Activity Insight: PLx Pharma
Shares of PLx Pharma (NASDAQ: PLXP) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $16.9.
Sentiment:Unusual Options Activity Insight: PLx Pharma
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 173 companies set new 52-week highs.
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 24)
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)
PLx Pharma Q1 Adj. EPS $(0.25) Misses $(0.21) Estimate
PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 32.43 percent increase over losses of $(0.37) per share from the